SUBRAHMANYESWARA SAMAVEDI, MD
Urology Physician in HAYS, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SUBRAHMANYESWARA SAMAVEDI, MD reported a CMS MIPS final score of 81.7643/100 — below the 83.1 national average — and filed 1,679 Medicare Part D claims in 2023.
- 81.7643/100
- MIPS score · -1 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SUBRAHMANYESWARA SAMAVEDI, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
82 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
SUBRAHMANYESWARA SAMAVEDI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SUBRAHMANYESWARA SAMAVEDI, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Kansas
How Urology Physician compares to other specialties among Kansas providers
Urology Physician share within Kansas
Urology Physician is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
SUBRAHMANYESWARA SAMAVEDI, MD's 2023 MIPS final score plotted against the Urology Physician national average
- MIPS Final Score
- 81.7643/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Urology Physician) — 81.7643/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Cost dim CMS Cost category
- Specialty volume Urology Physician US NPIs
81.7643/100 MIPS final score — 1.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Urology Physician. Cost dim: 52.0478.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SUBRAHMANYESWARA SAMAVEDI, MD appears in the CMS NPPES registry as a Urology Physician provider holding MD credentials at 2214 CANTERBURY DR STE 308, HAYS, KS, 67601, with a listed phone of (785) 628-6014. NPI 1811145212 was issued on 08/28/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SAMAVEDI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,679 prescription claims written by this provider, covering 436 Medicare beneficiaries and totaling roughly $120K in drug spend, with an opioid prescribing rate of 5.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.7643/100 for the 2023 performance year, compared with the national average of 83.1.
Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1811145212 |
|---|---|
| Specialty | Urology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/28/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SUBRAHMANYESWARA SAMAVEDI, MD's current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where SUBRAHMANYESWARA SAMAVEDI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUBRAHMANYESWARA SAMAVEDI, MD. Source: openpaymentsdata.cms.gov.
Total received
$183
Largest payer
PROCEPT BioRobotics Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,807
- Total Day Supply
- 75,578
- Generic Drug Cost
- $43K
- Opioid Claims
- 90 (5.4% rate)
- Antibiotic Claims
- 319
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.25
- Gender Split
- 19% female / 81% male
- Age Distribution
- <65: 34, 65-74: 215, 75-84: 138, 85+: 49
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SUBRAHMANYESWARA SAMAVEDI, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Tamsulosin Hcl
Tamsulosin Hcl
436 claims
- Finasteride
Finasteride
279 claims
- Ciprofloxacin Hcl 137
Ciprofloxacin Hcl
137 claims
- Oxybutynin Chlorid… 116
Oxybutynin Chloride Er
116 claims
- Myrbetriq 100
Myrbetriq
100 claims
- Solifenacin Succin… 87
Solifenacin Succinate
87 claims
- Dutasteride 59
Dutasteride
59 claims
- Nitrofurantoin 58
Nitrofurantoin
58 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 436 |
| Finasteride | 279 |
| Ciprofloxacin Hcl | 137 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 116 |
| Myrbetriq Mirabegron | 100 |
| Solifenacin Succinate | 87 |
| Dutasteride | 59 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 58 |
| Tramadol Hcl | 46 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Urology Physician Overview
How SUBRAHMANYESWARA SAMAVEDI, MD fits within the Urology Physician landscape nationally.
SUBRAHMANYESWARA SAMAVEDI, MD's 1,679 claims are above the specialty average of 1,280.
Nearby Urology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as SAMAVEDI.
Compare Urology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is SUBRAHMANYESWARA SAMAVEDI, MD's specialty? ▼
How much does SUBRAHMANYESWARA SAMAVEDI, MD prescribe under Medicare Part D? ▼
What is SUBRAHMANYESWARA SAMAVEDI, MD's Medicare quality score? ▼
Where is SUBRAHMANYESWARA SAMAVEDI, MD located? ▼
What is SUBRAHMANYESWARA SAMAVEDI, MD's NPI number? ▼
Does SUBRAHMANYESWARA SAMAVEDI, MD prescribe opioids? ▼
How many Urology Physician providers are there in the US? ▼
What drugs does SUBRAHMANYESWARA SAMAVEDI, MD prescribe most often? ▼
Does SUBRAHMANYESWARA SAMAVEDI, MD accept Medicare? ▼
How can I verify SUBRAHMANYESWARA SAMAVEDI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology